くる病治療の世界市場2019-2023

◆英語タイトル:Global Rickets Treatment Market 2019-2023
◆商品コード:IRTNTR31213
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年4月23日
◆ページ数:119
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥321,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、くる病治療の世界市場について調査・分析し、市場概要、市場環境、くる病治療市場規模、種類別(ビタミンD関係くる病、ミネラル関係くる病)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・くる病治療の世界市場概要
・くる病治療の世界市場環境
・くる病治療の世界市場動向
・くる病治療の世界市場規模
・くる病治療の世界市場:業界構造分析
・くる病治療の世界市場:種類別(ビタミンD関係くる病、ミネラル関係くる病)
・くる病治療の世界市場:地域別市場規模・分析
・くる病治療の北米市場規模・予測
・くる病治療のヨーロッパ・中東・アフリカ市場規模・予測
・くる病治療のアジア太平洋市場規模・予測
・くる病治療の主要国分析
・くる病治療の世界市場:意思決定フレームワーク
・くる病治療の世界市場:成長要因、課題
・くる病治療の世界市場:競争環境
・くる病治療の世界市場:関連企業情報(ベンダー分析)
【レポートの概要】

About this market

The growing awareness about vitamin D deficiency is one of the key factors expected to trigger market growth in the upcoming years. Rickets is often caused due to vitamin D deficiency in the body due to less exposure to the sun, dark skin, and the lack of vitamin D in the diet. Several programs are being initiated for creating public awareness about the health issues associated with vitamin D deficiency including rickets. Such rising awareness programs are further expected to boost the global rickets treatment market growth during the forecast period. Technavio’s analysts have predicted that the rickets treatment market will register a CAGR of nearly 6% by 2023.

Market Overview

Growing awareness about vitamin D deficiency

The increasing number of awareness programs are leading to the increasing diagnosis of the conditions caused by the deficiency of vitamin D, which, in turn, leading to the increasing use of supplements and drugs for the treatment.

Availability of substitute treatment options

Alternative therapies have a higher perceived value than the drugs, thereby the availability of substitute treatment options acts as a challenge to the growth of the global rickets treatment market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the rickets treatment market during 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several market players. The advent of biologics is encouraging companies to develop biological therapies, especially for the treatment of rare diseases. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY TYPE

Market segmentation by type

Comparison by type

Vitamin D-related rickets – Market size and forecast 2018-2023

Minerals-related rickets – Market size and forecast 2018-2023

Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 13: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

F. Hoffmann-La Roche Ltd

Merck KGaA

Novartis AG

Pfizer Inc.

Sanofi

PART 14: APPENDIX

Research methodology

List of abbreviations

Definition of vendors classification

PART 15: EXPLORE TECHNAVIO

Exhibit 01: Global pharmaceuticals market

Exhibit 02: Segments of global pharmaceuticals market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Market definition – Inclusions and exclusions checklist

Exhibit 06: Market size 2018

Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 09: Five forces analysis 2018

Exhibit 10: Five forces analysis 2023

Exhibit 11: Bargaining power of buyers

Exhibit 12: Bargaining power of suppliers

Exhibit 13: Threat of new entrants

Exhibit 14: Threat of substitutes

Exhibit 15: Threat of rivalry

Exhibit 16: Market condition – Five forces 2018

Exhibit 17: Type – Market share 2018-2023 (%)

Exhibit 18: Comparison by type

Exhibit 19: Vitamin D-related rickets – Market size and forecast 2018-2023 ($ millions)

Exhibit 20: Vitamin D-related rickets – Year-over-year growth 2019-2023 (%)

Exhibit 21: Minerals-related rickets – Market size and forecast 2018-2023 ($ millions)

Exhibit 22: Minerals-related rickets – Year-over-year growth 2019-2023 (%)

Exhibit 23: Market opportunity by type

Exhibit 24: Customer landscape

Exhibit 25: Market share by geography 2018-2023 (%)

Exhibit 26: Geographic comparison

Exhibit 27: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 28: North America – Year-over-year growth 2019-2023 (%)

Exhibit 29: Top 3 countries in North America

Exhibit 30: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 31: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 32: Top 3 countries in Asia

Exhibit 33: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 34: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 35: Top 3 countries in Europe

Exhibit 36: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 37: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 38: Top 3 countries in ROW

Exhibit 39: Key leading countries

Exhibit 40: Market opportunity

Exhibit 41: Strategic alliances in global rickets treatment market

Exhibit 42: Impact of drivers and challenges

Exhibit 43: Vendor landscape

Exhibit 44: Landscape disruption

Exhibit 45: Vendors covered

Exhibit 46: Vendor classification

Exhibit 47: Market positioning of vendors

Exhibit 48: F. Hoffmann-La Roche Ltd – Vendor overview

Exhibit 49: F. Hoffmann-La Roche Ltd – Product segments

Exhibit 50: F. Hoffmann-La Roche Ltd – Organizational developments

Exhibit 51: F. Hoffmann-La Roche Ltd – Geographic focus

Exhibit 52: F. Hoffmann-La Roche Ltd – Segment focus

Exhibit 53: F. Hoffmann-La Roche Ltd – Key offerings

Exhibit 54: F. Hoffmann-La Roche Ltd – Key customers

Exhibit 55: Merck KGaA – Vendor overview

Exhibit 56: Merck KGaA – Business segments

Exhibit 57: Merck KGaA – Organizational developments

Exhibit 58: Merck KGaA – Geographic focus

Exhibit 59: Merck KGaA – Segment focus

Exhibit 60: Merck KGaA – Key offerings

Exhibit 61: Merck KGaA – Key customers

Exhibit 62: Novartis AG – Vendor overview

Exhibit 63: Novartis AG – Business segments

Exhibit 64: Novartis AG – Organizational developments

Exhibit 65: Novartis AG – Geographic focus

Exhibit 66: Novartis AG – Segment focus

Exhibit 67: Novartis AG – Key offerings

Exhibit 68: Novartis AG – Key customers

Exhibit 69: Pfizer Inc. – Vendor overview

Exhibit 70: Pfizer Inc. – Business segments

Exhibit 71: Pfizer Inc. – Organizational developments

Exhibit 72: Pfizer Inc. – Geographic focus

Exhibit 73: Pfizer Inc. – Segment focus

Exhibit 74: Pfizer Inc. – Key offerings

Exhibit 75: Pfizer Inc. – Key customers

Exhibit 76: Sanofi – Vendor overview

Exhibit 77: Sanofi – Business segments

Exhibit 78: Sanofi – Organizational developments

Exhibit 79: Sanofi – Geographic focus

Exhibit 80: Sanofi – Segment focus

Exhibit 81: Sanofi – Key offerings

Exhibit 82: Sanofi – Key customers

Exhibit 83: Validation techniques employed for market sizing

Exhibit 84: Definition of vendors classification



【掲載企業】

F. Hoffmann-La Roche Ltd, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[くる病治療の世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆